SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000521
Filing Date
2017-07-18
Accepted
2017-07-18 16:54:52
Documents
1
Period of Report
2017-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4120
  Complete submission text file 0000904454-17-000521.txt   5479
Mailing Address ONE PALMER SQUARE PRINCETON NJ 08542
Business Address
DOVEY BRIAN H (Reporting) CIK: 0001207786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 17969980

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations